Aclaris Therapeutics, Inc. - Common Stock (ACRS)

89 filings reported holding ACRS - Aclaris Therapeutics, Inc. - Common Stock as of Q3 2019.
Aclaris Therapeutics, Inc. - Common Stock (ACRS) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 25.9M shares of 108M outstanding shares and own 23.92% of the company stock.
Largest 10 shareholders include Man Group plc (3.73M shares), Rock Springs Capital Management LP (2.97M shares), RENAISSANCE TECHNOLOGIES LLC (1.97M shares), Sofinnova Investments, Inc. (1.91M shares), Endurant Capital Management LP (1.77M shares), MORGAN STANLEY (1.73M shares), Broadfin Capital, LLC (1.62M shares), MFN Partners Management, LP (1.5M shares), VANGUARD GROUP INC (1.38M shares), and STATE STREET CORP (743K shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.